Newsfeed : Researchers Evaluate AIDS Vaccine Development

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
Newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Newsfeed » October 2008

Most Popular Links
Most Popular Lessons

The HIV Life Cycle

Shingles

Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

15 Years Ago In POZ


More News

Click here for more news

Have news about HIV? Send press releases, news tips and other announcements to news@poz.com.


emailprint

October 20, 2008

Researchers Evaluate AIDS Vaccine Development

Researchers at the weeklong International AIDS Vaccine Conference in Cape Town, South Africa—which ended October 17—voiced their disappointment in failing to discover an AIDS vaccine and said they are now forced to rethink their approach in combating the disease, Agence France-Presse (AFP) reports.

Last year, two advanced clinical trials of a vaccine created by pharmaceutical company Merck were terminated once it appeared they actually heightened the risk of AIDS infection. That news stunned scientists.

“They still don’t understand exactly what happened,” Mitchell Warren of the AIDS Vaccine Advocacy Coalition told AFP. “That finding forces people to realign and look at new ways and new approaches to how we are going to find an AIDS vaccine because it was so surprising.”

Alan Bernstein, director of the Global HIV Vaccine Enterprise, said that new research involves newly discovered defenses in the human body called the innate immune system, which works as an early warning system for invading diseases.

We now know the window of opportunity to stop HIV may be only hours—at most, days—after infection, he explained. “That’s reason to think this early warning system might be critical to activate if we are going to design a vaccine,” Bernstein said.

The difficulty in creating a vaccine is that HIV can mutate at such a rapid rate. While the setbacks have caused some to argue that funding could be better spent on other treatment or prevention efforts, others insist that vaccines provide the most cost-effective health intervention.

According to the article, about 30 trials are under way around the world. Results from a study in Thailand—which began in 2003—are expected in 2009.

Search: vaccine, Fauci, South Africa, Merck, AIDS Vaccine Conference, AIDS Vaccine Advocacy Coalition, Global HIV Vaccine Enterprise, Cape Town, Thailand


Scroll down to comment on this story.



Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules



Show comments (0 total)

 
[Go to top]

Facebook Twitter Google+ MySpace YouTube Tumblr Flickr Instagram
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar
POZ on Twitter

Ask POZ Pharmacist

Talk to Us
Poll
Have you ever been diagnosed with diabetes or pre-diabetes?
Yes
No

Survey
Pop Watch

more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.